Biotron Limited is an Australian biotechnology company developing and commercializing novel therapeutics and diagnostics to address a range of significant health issues.

Biotron's current focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company has a number of early-stage projects targeting other indications such as cardiovascular disease.

RECENT ANNOUNCEMENTS

Quarterly Report 30 September 2008

Presentation to Annual General Meeting

Resolutions Passed at Annual General Meeting

 

2008 Annual Report

BIT225-003: Phase Ib HCV Trial Information